EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Mitochondria‐Targeted Biomimetic Nanomedicine Capable of Reversing Drug Resistance in Colorectal Cancer Through Mitochondrial Dysfunction

Xiaohui Wang iD, Zhiyuan Xu, Jian Wang, Chunrong Wu, Lin Zhang, Chengyuan Qian, Yang Luo iD, Yanjuan Gu, Wing-Tak Wong iD, Debing Xiang iD

Advanced Science · 2025

DOI: 10.1002/advs.202410630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xiaohui Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing, 402260, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Drug Resistance, Neoplasm, Mitochondria, Nanomedicine. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Talents Project of Chongqing, Fundamental Research Funds for the Central Universities, Talent Project of Chongqing University Jiangjin Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemoresistance and metastasis are the main obstacles to the clinical success of anticancer treatment and are responsible for most cancer deaths. Developing effective approaches to reverse chemoresistance and inhibit metastasis is essential for efficient chemotherapy. Mitochondria are important sources of cellular energy and are involved in mediating chemoresistance and driving tumor metastasis. Due to the relatively weak DNA repair capacity of mitochondria, targeting mitochondria may reverse chemoresistance and provide a paradigm for metastatic cancer treatment. Herein, exosomes (Exos) modified with integrin ligands and mitochondriotropic molecules are synthesized for encapsulating oxaliplatin (OXA) to construct a sequentially targeted and mitochondrion‐dysfunctional nanodrug (OXA@Exo‐RD). Subsequent investigations confirm that OXA@Exo‐RD targeted cancer cells and mitochondria in sequence, and OXA delivered to mitochondria lacking DNA repair mechanisms reduce the likelihood of deactivation. Furthermore, the OXA@Exo‐RD promotes the overproduction of ROS, inhibited ATP generation, and induces mitochondria‐mediated apoptosis and mitochondrial dysregulation. Finally, OXA@Exo‐RD shows the potential to inhibit the growth and metastasis of HCT116/OXA cells in vitro, which is further validated in subcutaneous and orthotopic CRC models, as well as in CRC metastasis models. Taken together, this dual‐targeting nanomedicine induces apoptosis via mitochondrial signaling pathways, providing an attractive strategy for the treatment of drug‐resistant CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDrug Resistance, NeoplasmMitochondriaNanomedicineOxaliplatinHumansAnimalsMiceAntineoplastic AgentsBiomimeticsApoptosisReactive Oxygen SpeciesMice, NudeHCT116 CellsCell Line, Tumor

Stichwörter der Autor:innen

colorectal cancerdrug resistanceexosomemetastasismitochondrial dysfunction

Substanzen

OxaliplatinAntineoplastic AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Oncology, Chongqing University Jiangjin Hospital, Chongqing, 402260, China.
  • Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, SAR, China.
  • Department of Electrical and Electronic Engineering, The Hong Kong Polytechnic University, Hong Kong, SAR, China.
  • Department of Gastroenterology, Chongqing University Jiangjin Hospital, Chongqing, 402260, China.
  • Department of Laboratory Medicine, Chongqing General Hospital, School of Medicine, Chongqing University, Chongqing, 401147, China.

ORCID-Profile: Xiaohui Wang, Yang Luo, Wing-Tak Wong, Debing Xiang

Förderung

  • Talents Project of Chongqing
  • Fundamental Research Funds for the Central Universities
  • Talent Project of Chongqing University Jiangjin Hospital

Zitieren

APA

Wang, X., Xu, Z., Wang, J., Wu, C., Zhang, L., Qian, C., Luo, Y., Gu, Y., Wong, W. T., & Xiang, D. (2025). A Mitochondria‐Targeted Biomimetic Nanomedicine Capable of Reversing Drug Resistance in Colorectal Cancer Through Mitochondrial Dysfunction. Advanced Science. https://doi.org/10.1002/advs.202410630

Vancouver

Wang X, Xu Z, Wang J, Wu C, Zhang L, Qian C, et al. A Mitochondria‐Targeted Biomimetic Nanomedicine Capable of Reversing Drug Resistance in Colorectal Cancer Through Mitochondrial Dysfunction. Advanced Science. 2025. doi:10.1002/advs.202410630

BibTeX
@article{Wang2025,
  author = {Wang, Xiaohui and Xu, Zhiyuan and Wang, Jian and Wu, Chunrong and Zhang, Lin and Qian, Chengyuan and Luo, Yang and Gu, Yanjuan and Wong, Wing-Tak and Xiang, Debing},
  title = {A Mitochondria‐Targeted Biomimetic Nanomedicine Capable of Reversing Drug Resistance in Colorectal Cancer Through Mitochondrial Dysfunction},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202410630}
}
Kostenlos starten →